Skip to content

Author

Keyur Shah

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Chimeric IL-15 as a next-generation immunotherapeutic: preclinical assessment of efficacy and safety.

It is demonstrated that chimeric IL-15 induces robust antitumor immunity with improved pharmacokinetics and a favourable safety profile, supporting its further preclinical development as a next-generation cancer immunotherapeutic.

Himali Patel, M. Ahuja, Keyur Shah et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.